Items where authors include "Anderson, N."

Number of items: 13.

Article

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Kyte, D., Fletcher, B., Horton, M. orcid.org/0000-0002-6675-7335 et al. (12 more authors) (2025) Development, Rasch analysis and validation of the kidney symptom burden questionnaire (KSB-Q). Clinical Kidney Journal, 18 (5). sfaf112. ISSN 2048-8505

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Crossnohere, N.L. orcid.org/0000-0002-2811-1330, Anderson, N., Baumhauer, J. orcid.org/0000-0003-2142-7778 et al. (15 more authors) (2024) A framework for implementing patient-reported outcomes in clinical care: the PROTEUS-practice guide. Nature Medicine, 30. pp. 1519-1520. ISSN 1078-8956

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Anderson, N., Habib, B., Harris, S. et al. (2 more authors) (2022) Racial capitalism and the school geography curriculum. Teaching Geography, 2022 (Spring). pp. 15-18. ISSN 0305-8018

Conference or Workshop Item

Crossnohere, N., Anderson, N., Baumhauer, J. et al. (15 more authors) (2024) HSD71 Implementing Patient-Reported Outcomes in Clinical Practice: The PROTEUS-Practice Framework & Guide. In: ISPOR 2024, 05-08 May 2024, Atlanta, USA.

Proceedings Paper

Kunkler, I., Russell, N., Anderson, N. et al. (21 more authors) (2025) Abstract GS2-03: Does postmastectomy radiotherapy in 'intermediate-risk' breast cancer impact overall survival? 10 year results of the BIG 2-04 MRC SUPREMO randomised trial: on behalf of the SUPREMO trial investigators. In: Clinical Cancer Research. San Antonio Breast Cancer Symposium 2024, 10-13 Dec 2024, Texas, USA. American Association for Cancer Research (AACR) .

This list was generated on Wed Oct 1 20:33:35 2025 BST.